Ledger.Open graph →
SEC Form D · filed December 12, 2019

VistaGen Therapeutics, Inc

Offering
$650K
Sold
$650K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Brian J. Underdown · South San Francisco, CADirectorShawn K. Singh · South San Francisco, CAExec · DirectorBarrett R. Sigmund · Seattle, WAExecAsia Capital Management, L.P · Grand Cayman, Cayman IslandsExec · DirectorAnn K. Cunningham · South San Francisco, CADirectorJerry B. Gin · South San Francisco, CADirectorMark W. Brooker · Houston, TXDirectorSteve Wallace · Richmond, VAExecYanghee Paik · Buena Park, CAExecPaul G. Roess · Chattanooga, TNExec · DirectorR. D. Ravnaas · Forth Worth, TXDirectorMark A. Mcpartland · South San Francisco, CAExecJerrold D. Dotson · South San Francisco, CAExecJoon H. Hwang · Seoul, M5DirectorMark A. Smith · South San Francisco, CAExecIshaan Nerurkar · Berkeley, CADirectorMark Rose · Chicago, ILExec · DirectorColton Jang · Berkeley, CAExecJon S. Saxe · South San Francisco, CADirectorH. R. Snodgrass · South San Francisco, CAExec · DirectorThomas P. Hoban, Jr · EVERETT, WADirectorDonna Edmonds · Richmond, VADirectorTyler Tringas · Miami, FLDirectorEarl Webb · Chicago, ILExecMichael Theilmann · Berkeley, CAExec · DirectorScott Gazelle · Richmond, VADirectorMark W. Piper · SEATTLE, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗